₹1,445.80 21.55 (1.51%)
02:15 PM, 9-Feb-2026₹1,447.40 30.70 (2.17%)
02:04 PM, 9-Feb-2026BSE : 524494
NSE : IPCALAB
Sector : Health care
ISIN Code : INE571A01038
Last Updated: 09-Feb-2026 | 02:15 PM IST
| Market Cap (₹ Cr) | 36,680 |
Traded Value (₹ Cr) | 0.51 |
Volume (Shares) | 3,557 |
Face Value (₹) | 1 |
52-Week High (₹) | 1,594.55 |
52-Week High Date | 25-Jul-2025 |
52-Week Low (₹) | 1,200.00 |
52-Week Low Date | 07-Apr-2025 |
All Time High (₹) | 1,757.65 |
All Time High Date | 03-Jan-2025 |
All Time Low (₹) | 2.83 |
All Time Low Date | 18-Sep-2001 |
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 36,642 |
| EPS - TTM (₹) [C] | 33.65 |
| P/E Ratio (X) [C] | 42.92 |
| Face Value (₹) | 1 |
| Latest Dividend (%) | 200.00 |
| Latest Dividend Date | 05-Aug-2025 |
| Dividend Yield (%) | 0.28 |
| Book Value Share (₹) [C] | 292.74 |
| P/B Ratio (₹) [C] | 4.93 |
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Nippon India Growth Mid Cap Fund - (IDCW) | 455.95 | 31,00,000 | 1.09 |
| Nippon India Growth Mid Cap Fund - Direct (G) | 455.95 | 31,00,000 | 1.09 |
| Nippon India Growth Mid Cap Fund - (G) | 455.95 | 31,00,000 | 1.09 |
| Nippon India Growth Mid Cap Fund - (Bonus) | 455.95 | 31,00,000 | 1.09 |
| Nippon India Growth Mid Cap Fund - Direct (Bonus) | 455.95 | 31,00,000 | 1.09 |
| Nippon India Growth Mid Cap Fund - Inst (IDCW) | 455.95 | 31,00,000 | 1.09 |
| Nippon India Growth Mid Cap Fund - Direct (IDCW) | 455.95 | 31,00,000 | 1.09 |
| UTI-Flexi Cap Fund - Direct (IDCW) | 205.76 | 13,99,000 | 0.87 |
| UTI-Flexi Cap Fund - Direct (G) | 205.76 | 13,99,000 | 0.87 |
| UTI-Flexi Cap Fund (IDCW) | 205.76 | 13,99,000 | 0.87 |
Load more
| Today's Low/High (₹) | 1,416.00 1,447.90 |
| Week Low/High (₹) | 1,391.80 1,470.00 |
| Month Low/High (₹) | 1,391.80 1,583.00 |
| Year Low/High (₹) | 1,168.20 1,595.00 |
| All time Low/High (₹) | 2.83 1,756.00 |
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 0.31% | 0.31% | 2.86% | 3.02% |
| 1 Month | -7.98% | -8.30% | 0.51% | 0.64% |
| 3 Month | 9.27% | 9.56% | 0.95% | 1.39% |
| 6 Month | 4.32% | 4.15% | 5.19% | 6.09% |
| 1 Year | -4.11% | -4.18% | 7.89% | 9.71% |
| 3 Year | 64.86% | 64.74% | 38.15% | 44.45% |
Executive Chairman : Premchand Godha
Managing Director & CFO : A K Jain
Managing Director & Chief Executive Officer : Pranay Godha
Executive Director : Prashant Godha
Independent Non Exe. Director : Kamal Kishore Seth
Independent Non Exe. Director : Narendra Mairpady
Company Sec. & Compli. Officer : Harish P Kamath
Independent Director : Swati Patankar
Independent Director : Vivek Shiralkar
Registered Office: 48 Kandivli Industrial Estate, Kandivli (West),Mumbai,Maharashtra-400067 Ph: 91-22-66474444
1. What's the Ipca Laboratories Ltd share price today?
Ipca Laboratories Ltd share price was Rs 1,445.80 at 02:15 PM IST on 9th Feb 2026. Ipca Laboratories Ltd share price was up by 1.51% over the previous closing price of Rs 1,424.25. Ipca Laboratories Ltd share price trend:
2. How can I quickly analyse the performance of the Ipca Laboratories Ltd stock?
The performance of the Ipca Laboratories Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Ipca Laboratories Ltd?
Ipca Laboratories Ltd has a market capitalisation of Rs 36,680 crore.
4. What is Ipca Laboratories Ltd's 52-week high/low share price?
The Ipca Laboratories Ltd’s 52-week high share price is Rs 1,594.55 and 52-week low share price is Rs 1,200.00.
5. Is the Ipca Laboratories Ltd profitable?
On a consolidated basis, Ipca Laboratories Ltd reported a profit of Rs 283.50 crore on a total income of Rs 2,584.36 crore for the quarter ended 2025.
6. Which are Ipca Laboratories Ltd’s peers in the Health care sector?
Ipca Laboratories Ltd’s top 5 peers in the Health care sector are Laurus Labs, Glaxosmi. Pharma, Anthem Bioscienc, Ipca Labs., Ajanta Pharma, Gland Pharma, J B Chemicals &.
7. Who owns how much in Ipca Laboratories Ltd?
Key changes to the Ipca Laboratories Ltd shareholding are as follows: